138 related articles for article (PubMed ID: 10389728)
1. Urine free beta-hCG and total estriol for Down syndrome screening during the second trimester in an Asian population.
Hsu JJ; Hsu TY; Hsieh TT; Soong YK; Hsieh FJ; Spencer K
Obstet Gynecol; 1999 Jul; 94(1):107-11. PubMed ID: 10389728
[TBL] [Abstract][Full Text] [Related]
2. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
Hsu JJ; Hsieh TT; Hsieh FJ
Obstet Gynecol; 1996 Jun; 87(6):943-7. PubMed ID: 8649703
[TBL] [Abstract][Full Text] [Related]
4. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
5. Elevated second-trimester maternal urine free beta-human chorionic gonadotropin levels in Asian pregnancies with fetal chromosomal abnormalities.
Hsu JJ; Hung TH; Liou JD; Hsieh TT; Soong YK
Fetal Diagn Ther; 1998; 13(6):352-6. PubMed ID: 9933818
[TBL] [Abstract][Full Text] [Related]
6. Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
Kellner LH; Canick JA; Palomaki GE; Neveux LM; Saller DN; Walker RP; Osathanondh R; Bombard AT
Prenat Diagn; 1997 Dec; 17(12):1135-41. PubMed ID: 9467810
[TBL] [Abstract][Full Text] [Related]
7. Screening for Down syndrome using urine hCG free beta-subunit in the second trimester of pregnancy.
Cole LA; Jacobs M; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MJ
Prenat Diagn; 1997 Dec; 17(12):1107-11. PubMed ID: 9467807
[TBL] [Abstract][Full Text] [Related]
8. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
9. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
10. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K; Noble P; Snijders RJ; Nicolaides KH
Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
[TBL] [Abstract][Full Text] [Related]
11. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
12. Urinary screening tests for fetal Down syndrome: I. Fresh beta-core fragment.
Cole LA; Rinne KM; Mahajan SM; Oz UA; Shahabi S; Mahoney MJ; Bahado-Singh RO
Prenat Diagn; 1999 Apr; 19(4):340-50. PubMed ID: 10327140
[TBL] [Abstract][Full Text] [Related]
13. Free beta-hCG subunit versus intact hCG in Down syndrome screening.
Wenstrom KD; Owen J; Chu DC; Boots L
Obstet Gynecol; 1997 Sep; 90(3):370-4. PubMed ID: 9277646
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
[TBL] [Abstract][Full Text] [Related]
15. Comparison of triple-risk assessment of fetal trisomy 21 including total human choriogonadotropin (hCG) or its free beta-subunit (free beta hCG).
Sancken U; Bahner D
Fetal Diagn Ther; 2003; 18(2):122-7. PubMed ID: 12576748
[TBL] [Abstract][Full Text] [Related]
16. Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan.
Hsieh TT; Hsu JJ; Cheng PJ; Lee CN; Jou HJ; Chen CP
Taiwan J Obstet Gynecol; 2007 Sep; 46(3):230-5. PubMed ID: 17962101
[TBL] [Abstract][Full Text] [Related]
17. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies.
Cole LA; Kellner LH; Isozaki T; Palomaki GE; Iles RK; Walker RP; Ozaki M; Canick JA
Prenat Diagn; 1997 Jul; 17(7):607-14. PubMed ID: 9249860
[TBL] [Abstract][Full Text] [Related]
19. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
20. Collaborative study of maternal urine beta -core human chorionic gonadotrophin screening for Down syndrome.
Cuckle HS; Canick JA; Kellner LH
Prenat Diagn; 1999 Oct; 19(10):911-7. PubMed ID: 10521814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
